fbpx

Lyka Labs Ltd

LYKA.NS

$1.81

Closing

▲0.61%

1D

▼-1.03%

YTD

LYKA

BBG001S83YR2

Exchange

Sector

Market cap

$64.50M

Volume

118,582

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$64.50M

Analysts' Rating

-

Price Target (Mean)

0.00

Total Analysts

0

P/E

169.31

Operating Margin

2.62%

Beta

1.40

Revenue Growth

47.05%

52 week high

$2.05

52 week low

$1.14

Div. Yield

%

EPS Growth

0.00

Company Profile

Lyka Labs Limited is an India-based pharmaceutical company engaged in the development, manufacture and marketing of quality finished dosages. The Company manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Markets and the Domestic Market. The Company’s R&D is engaged in the development of new formulations and has developed several products in the categories, such as Injectables: Lyophilized Injection, Liquid Injections & Dry Powder Injections, and Topical Preparation: Ointment /Creams and Lotions. It offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, antifungal, anti-malarial, antibacterial, corticosteroid hormones and cephalosporins. The Company’s subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.